Evidence map›Paper›PMID 34179082›Full record

ReviewFrontiers in molecular biosciences2021

Learning the Regulatory Code of Gene Expression.

Jan Zrimec, Filip Buric, Mariia Kokina, Victor Garcia, Aleksej Zelezniak

Abstract readReview
In one paragraph

Review in Frontiers in molecular biosciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Using supervised machine-learning approaches to understand abiotic stress tolerance and design resilient crops.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Promoters in Pichia pastoris: A Toolbox for Fine-Tuned Gene Expression.Methods in molecular biology (Clifton, N.J.) · 2024
    Review
  13. Review
  14. Article
  15. Network-based approaches for modeling disease regulation and progression.Computational and structural biotechnology journal · 2023
    Review
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jan ZrimecDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Filip BuricDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Mariia KokinaDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Victor GarciaSchool of Life Sciences and Facility Management, Zurich University of Applied Sciences, Wädenswil, Switzerland.
Aleksej ZelezniakDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data-driven machine learning is the method of choice for predicting molecular phenotypes from nucleotide sequence, modeling gene expression events including protein-DNA binding, chromatin states as well as mRNA and protein levels. Deep neural networks automatically learn informative sequence representations and interpreting them enables us to improve our understanding of the regulatory code governing gene expression. Here, we review the latest developments that apply shallow or deep learning to quantify molecular phenotypes and decode the

Indexed as

chromatin accessibilitycis-regulatory grammardeep neural networksgene expression predictiongene regulatory structuremachine learningmRNA & protein abundanceregulatory genomics

Identifiers

PMID34179082
PMCPMC8223075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.